Esta web utiliza cookies. Si continúas navegando consideramos que aceptas su uso.
Más información
Aceptar
Molecular Inflammation Group
Log in
Contact
Legal Notice
Home
Home
Projects
Publications
Thesis
Members
Colaborations
News
Events
Calls
Calendar
Teaching resources
Inflammasome Journal
Publications
Cargando...
New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis.
Re OL, Lopez-Lopez V, Balaguer-Roman A, Martinez-Sanchez MA, Eshmuminov D, Llamoza-Torres CJ, Miura K, Baroja-Mazo A, Ramirez P, Robles-Campos R, Ramos-Molina B. New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis. Langenbecks Arch Surg. 2023 Mar 31;408(1):134. doi: 10.1007/s00423-023-02867-8. PubMed PMID: 37000331.
Journal: LANGENBECKS ARCHIVES OF SURGERY
AÑO: 2023; IF: 2.895
37000331
Clinical Significance of the Pre-Transplant CXCR3 and CCR6 Expression on T Cells In Kidney Graft Recipients.
Alfaro R, Llorente S, Gonzalez-Martinez G, Jimenez-Coll V, Martinez-Banaclocha H, Galian JA, Botella C, Moya-Quiles MR, de la Pena-Moral J, Minguela A, Legaz I, Muro M. Clinical Significance of the Pre-Transplant CXCR3 and CCR6 Expression on T Cells In Kidney Graft Recipients. Transplant Proc. 2023 Jan 6:S0041-1345(22)00883-1. doi: 10.1016/j.transproceed.2022.12.012. Online ahead of print. PubMed PMID: 36621349.
Journal: TRANSPLANTATION PROCEEDINGS
AÑO: 2023; IF: 1.014
36621349
Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis.
Millet V, Gensollen T, Maltese M, Serrero M, Lesavre N, Bourges C, Pitaval C, Cadra S, Chasson L, Vu Man TP, Masse M, Martinez-Garcia JJ, Tranchida F, Shintu L, Mostert K, Strauss E, Lepage P, Chamaillard M, Broggi A, Peyrin-Biroulet L, Grimaud JC, Naquet P, Galland F. Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis. Gut. 2022 Sep 29. pii: gutjnl-2021-325792. doi: 10.1136/gutjnl-2021-325792. [Epub ahead of print] PubMed PMID: 36175116.
Journal: GUT
AÑO: 2022; IF: 31.793
36175116
The future of neuroimmunology research for CNS disease therapeutics.
Lambris JD, Rosenthal A, Pelegrin P, Tremblay ME, Chen P. The future of neuroimmunology research for CNS disease therapeutics. Trends Pharmacol Sci. 2022 Aug;43(8):611-614. doi: 10.1016/j.tips.2022.06.003. No abstract available. PubMed PMID: 35839748.
Journal: TRENDS IN PHARMACOLOGICAL SCIENCES
AÑO: 2022; IF: 17.638
35839748
NLRP3 and pyroptosis blockers for treating inflammatory diseases.
Coll RC, Schroder K, Pelegrin P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci. 2022 Aug;43(8):653-668. doi: 10.1016/j.tips.2022.04.003. Epub 2022 May 3. PubMed PMID: 35513901.
Journal: TRENDS IN PHARMACOLOGICAL SCIENCES
AÑO: 2022; IF: 17.638
35513901
< Anterior
Siguiente >
Instituto de Investigación Sanitaria Acreditado
Molecular Inflammation Group
Home
Projects
Publications
Thesis
Members
Colaborations
News
Events
Calls
Calendar
Teaching resources
Inflammasome Journal